SEC Charges Cassava Sciences, Former Executives for Misleading Claims in Alzheimer's Trial
Cassava Sciences Inc SAVA
News
Cassava Sciences settles SEC charges of 'misleading' Alzheimer's trial claims
Cassava Sciences Resolves SEC Investigation
Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
Cassava Sciences Names Rick Barry as Chief Executive Officer
Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference
Cassava Sciences Reports Q2 2024 Financial Results and Operational Updates
Cassava Sciences Mourns the Death of Board Member Sanford “Sandy” Robertson
Cassava Sciences to Hold Conference Call to Discuss Recent Developments and Provide a Company Update on Thursday, August 8, 2024 at 8:30 am ET
Cassava Sciences Announces Expansion of Open-Label Extension Trials
Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives
Cassava Sciences shares fall after onetime advisor indicted on fraud charges
Cassava Sciences' Shares Down 46% After Adviser Is Indicted
Cassava Sciences Issues Statement on Former Science Advisor
Cassava shares plummet after investigation accuses researcher of 'egregious misconduct'
Tech stocks like Amazon and CrowdStrike will rip higher this earnings season, says Wedbush's Ives. Here's why.
ViaSat shares surge after saying it won't replace satellite as Dollar General stock rises on CEO return
United States